Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3Other hematologic neoplasm 2Lymphoid 1Gynecologic 1Gastrointestinal 1CNS 1Breast 1

Conditions

Brain Neoplasms 1

Interventions

Temozolomide 44Magnetic Resonance Spectroscopy 40Specimen Handling 29Radiotherapy 19Radiation 16Bevacizumab 14Biopsy 13Radiosurgery 12Nivolumab 12X-Rays 10Cyclophosphamide 9Carboplatin 9Nuclear Medicine Department, Hospital 7Lomustine 7Irinotecan 7pembrolizumab 6Ipilimumab 6Cisplatin 6AZD 6244 6Vincristine 5Topotecan 5Phantoms, Imaging 5Etoposide 5CTLA-4 Antigen 5ulixertinib 4trametinib 4olaparib 4erdafitinib 4dinutuximab 4binimetinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Positron-Emission Tomography × CNS × 30 days × Clear all
NCT06015295 2026-06-02

A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for Detecting True-versus Pseudo-Progression of Brain Metastases on Immunotherapy

M.D. Anderson Cancer Center

Phase NA Active not recruiting
3 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡